TrialLeukemia2020

Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.

Stuart J Blakemore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.